Linked Life Data

15018081

Source:http://linkedlifedata.com/resource/pubmed/id/15018081

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2004-3-15
pubmed:abstractText
Many improvements have been made regarding the management of prostate cancer. The standard therapeutic options for localised prostate cancer remain radical prostatectomy, external beam radiation therapy, and brachytherapy. However, some minimally invasive treatments are being investigated, including high intensity focused ultrasound and cryotherapy. In the future these therapies may replace standard treatments in selected patients. On the other hand, only few advances have been made in the treatment of non-localised prostate cancer. Locally advanced cancer is treated with combination of radiotherapy and hormonotherapy, and metastatic cancer is treated with hormone therapy. Docetaxel may improve patient survival in hormone-refractory disease.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0035-2640
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2263-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
[Therapeutic options and controversies in the management of prostate cancer].
pubmed:affiliation
Service d'urologie, hôpital Cochin, 75679 Paris 14. michael.peyromaure@cch.ap-hop-paris.fr
pubmed:publicationType
Journal Article, Comparative Study, English Abstract